Susquehanna International Group’s Immune Design Corp. IMDZ Stock Holding History

Susquehanna International Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,500	Closed	-$48K	–	11058
2018 Q1	$48K	Sell	14,500 -5,800	-29%	-$20.5K	﹤0.01%	8968
2017 Q4	$79K	Buy	+20,300	New	+$111K	﹤0.01%	8777
2017 Q2	–	Sell	-40,500	Closed	-$275K	–	10462
2017 Q1	$275K	Buy	+40,500	New	+$234K	﹤0.01%	7484

Susquehanna International Group's IMDZ Position: Q1 2019 in Review

Susquehanna International Group sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 35,287 shares — an estimated $120K sold.

Susquehanna International Group first reported a position in IMDZ in Q4 2016 and held it in 5 quarters. The position peaked at $170K in Q1 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Susquehanna International Group reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Susquehanna International Group sold 35,287 Immune Design Corp. shares in Q1 2019, an estimated $120K.
Susquehanna International Group first reported a position in Immune Design Corp. in Q4 2016 and held it in 5 quarters.
Susquehanna International Group's Immune Design Corp. position peaked at $170K in Q1 2018.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.